Biostock: PHI comments on expansion into veterinary IVF

October 17, 2025
Language flag

Phase Holographic Imaging is broadening its focus. The company, which previously operated in regenerative medicine and cell therapy, is now adding the fast-growing field of in vitro fertilization, IVF, for livestock to its pipeline. BioStock contacted CEO Patrik Eschricht to learn more about the decision and what opportunities he sees with the new venture.

Our expansion into veterinary IVF stems from both strategic insight and opportunity. Over the years, PHI has built a unique competence in quantitative phase imaging (QPI) and live-cell analysis – technologies that provide powerful, label-free insights into cell behavior. When evaluating new application areas, we saw that the IVF field, both human and veterinary, could greatly benefit from our ability to monitor cell health, development, and morphology in real time.

Patrik Eschricht, CEO
Read the full interview at Biostock

Latest News

A brown cow with a calf on a green field-

PHI sets sights on IVF applications in livestock

Phase Holographic Imaging PHI AB (“PHI” or the “Company”), a leading provider of advanced holographic imaging solutions, announces its strategic expansion into in vitro fertilization (IVF) in livestock – a growing field where advanced imaging can improve the assessment of oocytes and embryos in livestock breeding. The initiative leverages PHI’s core Quantitative Phase Imaging (QPI) technology and will explore how label-free, non-invasive imaging can make IVF in cows and horses more consistent, efficient, and scalable. PHI’s next-generation HoloMonitor®, which the new IVF-initiative is based on, is set to be launched later this year and PHI has officially filed a trademark application for HoloOocyte.
wetransfer_4

Interim Report 1 2025/26

The first quarter of the fiscal year marks a pivotal moment for PHI as we continue to build momentum across our strategic pillars. Our commitment to innovation, clinical integration, and global expansion remains steadfast, and the progress made this quarter reflects the dedication and ingenuity of our entire team.

Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)

The shareholders of Phase Holographic Imaging PHI AB (publ), reg.no. 556542-7811, are hereby invited to attend the annual general meeting on 16 October 2025 at 3 p.m. at the company´s office at Skiffervägen 48 in Lund.
See All News